Acurx Pharmaceuticals, Inc. (ACXP) Q4 2024 Earnings Call Transcript

2025-03-18 09:44:50 ET

Acurx Pharmaceuticals, Inc. (ACXP)

Q4 2024 Earnings Conference Call

March 18, 2025, 8:00 AM ET

Company Participants

Robert Shawah - Co-Founder and Chief Financial Officer

David Luci - President and Chief Executive Officer

Conference Call Participants

Thomas Yip - H.C. Wainwright

James Molloy - Alliance Global Partners

Claire Acheson - Independent Investment Research

Presentation

Operator

Greetings and welcome to the Acurx Pharmaceuticals Fourth Quarter and Full Year 2024 Financial Results and Business Update. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

I'll now turn the conference over to your host Mr. Robert Shawah, Chief Financial Officer for Acurx Pharmaceuticals. Please go ahead, sir.

Robert Shawah

Thank you, Melissa. Good morning and welcome to our call. This morning, we issued a press release providing financial results and company highlights for the fourth quarter and full year 2024, which is available on our website at acurxpharma.com....

Read the full article on Seeking Alpha

For further details see: